butonate: structure
ID Source | ID |
---|---|
PubMed CID | 31343 |
CHEMBL ID | 1570266 |
CHEBI ID | 82106 |
SCHEMBL ID | 117990 |
MeSH ID | M0049642 |
Synonym |
---|
brn 1813429 |
o,o-dimethyl-(1-n-butyryloxy-2,2,2-trichloraethyl)-phosphonsaeureester |
dimethyl 2,2,2-trichloro-1-n-butyryloxyethylphosphonate |
einecs 204-778-4 |
o,o-dimethyl-2,2,2-trichloro-1-phosphonoethyl butyrate |
butonate [iso] |
pedix-butonate |
dimethyl (2,2,2-trichloro-1-butyryloxyethyl)phosphonate |
fekama at 50 |
butonatum [inn-latin] |
dimethyl 1-butyryloxy-2,2,2-trichloroethylphosphonate |
butyric acid, ester with dimethyl (2,2,2-trichloro-1-hydroxyethyl)phosphonate |
nsc 17872 |
epa pesticide chemical code 035701 |
butonato [inn-spanish] |
phosphonic acid, (2,2,2-trichloro-1-hydroxyethyl)-, dimethyl ester, butyrate |
ent 20,852 |
o,o-dimethyl-(1-butyryloxy-2,2,2-trichloroethyl) phosphonate |
2,2,2-trichloro-1-(dimethoxyphosphinyl)ethyl butanoate |
butonat [german] |
pedix pe 50 |
o,o-dimethyl-2,2,2-trichloro-1-n-butyryloxyethyl phosphonate |
dimethyl (2,2,2-trichloro-1-hydroxyethyl)phosphonate butyric acid ester |
o,o-dimethyl (2,2,2-trichloro-1-n-butyryloxyethyl)phosphonate |
o,o-dimethyl (2,2,2-trichloro-1-hydroxyethyl) phosphonate ester of butyric acid |
caswell no. 385a |
f 139 |
pedix-50 |
dimethoxy-2,2,2-trichloro-1-n-butyryloxy-ethylphospine oxide |
hsdb 1595 |
ai3-20852 |
D03194 |
butonate (usan/inn) |
butanoic acid,2,2-trichloro-1-(dimethoxyphosphinyl)ethyl ester |
dimethyl (2,2-trichloro-1-hydroxyethyl)phosphonate ester of butyric acid |
dimethoxy-2,2-trichloro-1-n-butyryloxy-ethylphosphine oxide |
butyric acid,2,2-trichloro-1-hydroxyethyl)phosphonate |
ent-20852 |
butonate |
o,2,2-trichloro-1-n-butyryloxyethyl)phosphonate |
0,2,2-trichloro-1-(n-butyryloxy)ethylphosphonate |
butyric acid ester of dimethyl (2,2-trichloro-1-hydroxyethyl)phosphonate |
tribufon |
butanoic acid 2,2-trichloro-1-(dimethoxyphosphinyl)ethyl ester |
phosphonic acid,2,2-trichloro-1-hydroxyethyl)-, dimethyl ester, butyrate |
126-22-7 |
wln: gxggyov3 & po & o1 & o1 |
f-139 |
dimethyl 2,2-trichloro-1-n-butyryloxyethylphosphonate |
nsc-17872 |
t-113 , |
dimethyl 2,2-trichloro-1-butyryloxyethylphosphonate |
butilchlorofos |
nsc17872 |
(2,2,2-trichloro-1-dimethoxyphosphoryl-ethyl) butanoate |
BUT , |
butanoic acid, 2,2,2-trichloro-1-(dimethoxyphosphinyl)ethyl ester |
2,2,2-trichloro-1-(dimethoxyphosphoryl)ethyl butyrate |
0, 0-dimethyl 2,2,2-trichloro-1-(n-butyryloxy)ethylphosphonate |
butanoic acid 2,2,2-trichloro-1-(dimethoxyphosphinyl)ethyl ester |
NCGC00160570-01 |
(2,2,2-trichloro-1-dimethoxyphosphorylethyl) butanoate |
butonato |
unii-39m9r3q494 |
butonat |
39m9r3q494 , |
butonate [usan:inn] |
butonatum |
C18967 |
dtxcid3021697 |
cas-126-22-7 |
tox21_111908 |
dtxsid5041697 , |
AKOS024332382 |
trichlorfon butanoic acid ester |
chebi:82106 , |
CHEMBL1570266 |
SCHEMBL117990 |
butonate [hsdb] |
butonate [inn] |
(rs)-2,2,2-trichloro-1-(dimethoxyphosphinoyl)ethyl butyrate |
butonate [usan] |
trichlorfon butanoic acid ester [mi] |
butonate [green book] |
BKAQXYNWONVOAX-UHFFFAOYSA-N |
Q27155753 |
DB11379 |
o,o-dimethyl 2,2,2-trichloro-1-butyryloxyethylphosphonate |
Excerpt | Reference | Relevance |
---|---|---|
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs." | ( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019) | 0.51 |
Class | Description |
---|---|
fatty acid ester | A carboxylic ester in which the carboxylic acid component can be any fatty acid. |
butyrate ester | Any carboxylic ester where the carboxylic acid component is butyric acid. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
GLS protein | Homo sapiens (human) | Potency | 35.4813 | 0.3548 | 7.9355 | 39.8107 | AID624170 |
TDP1 protein | Homo sapiens (human) | Potency | 0.1189 | 0.0008 | 11.3822 | 44.6684 | AID686979 |
AR protein | Homo sapiens (human) | Potency | 20.7510 | 0.0002 | 21.2231 | 8,912.5098 | AID743040; AID743053 |
estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 16.6307 | 0.0002 | 29.3054 | 16,493.5996 | AID743069; AID743075; AID743079; AID743080; AID743091 |
aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 33.4915 | 0.0007 | 23.0674 | 1,258.9301 | AID743085; AID743122 |
nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 0.0063 | 0.0079 | 8.2332 | 1,122.0200 | AID2551 |
lamin isoform A-delta10 | Homo sapiens (human) | Potency | 35.4813 | 0.8913 | 12.0676 | 28.1838 | AID1487 |
Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Potency | 63.0957 | 0.0096 | 10.5250 | 35.4813 | AID1479145 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Process | via Protein(s) | Taxonomy |
---|---|---|
virion membrane | Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus |
[Information is prepared from geneontology information from the June-17-2024 release] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID504749 | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | 2011 | Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043 | Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets. |
AID1296008 | Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | 2020 | SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1 | Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. |
AID1346987 | P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5 | A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
AID1346986 | P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5 | A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 7 (63.64) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 2 (18.18) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (46.93) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |